4
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis

      systematic-review

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          This study aimed to assess the efficacy and safety of Chinese herbal medicine (CHM) plus conventional western medicine (CWM) in comparison with CWM against COVID-19.

          Methods

          We searched eight electronic databases and three trial registers spanning from January 1, 2020 to May 18, 2023. We included randomized controlled trials (RCTs) comparing the effectiveness and safety of CHM plus CWM and CWM against COVID-19 in our study. The Cochrane Risk of Bias tool 2.0 (RoB2) was applied to evaluate the methodological quality of the included RCTs. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system was employed to assess the certainty of evidence. Statistical analysis was implemented in R version 4.1.2.

          Results

          Our study included 50 RCTs involving 11,624 patients. In comparison with sole CWM, CHM plus CWM against COVID-19 significantly enhanced clinical effective rate (RR = 1.18, 95% CI [1.13, 1.22]), improved chest image (RR = 1.19, 95% CI [1.11, 1.28]), inhibited clinical deterioration (RR = 0.45, 95% CI [0.33, 0.60]), lowered mortality (RR = 0.53, 95% CI [0.40, 0.70]), and reduced the total score of TCM syndrome (SMD = −1.24, 95% CI [−1.82, −0.66]). SARS-CoV-2 nucleic acid conversion time (MD = −2.66, 95% CI [−3.88, −1.44]), duration of hospitalization (MD = −2.36, 95% CI [−3.89, −0.82]), and clinical symptom (fever, cough, fatigue, and shortness of breath) recovery times were shorter in CHM plus CWM groups than in CWM groups. Further, CHM plus CWM treatment was more conducive for some laboratory indicators returning to normal levels. No statistical difference was found in the incidence of total adverse reactions between the two groups (RR = 0.97, 95% CI [0.88, 1.07]). We assessed the risk of bias for 246 outcomes, and categorized 55 into “low risk”, 151 into “some concerns”, and 40 into “high risk”. Overall, the certainty of the evidence ranged from moderate to very low.

          Conclusions

          Potentially, CHM listed in this study, as an adjunctive therapy, combining with CWM is an effective and safe therapy mode for COVID-19. However, more high-quality RCTs are needed to draw more accurate conclusions.

          Related collections

          Most cited references105

          • Record: found
          • Abstract: not found
          • Article: not found

          Bias in meta-analysis detected by a simple, graphical test

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            RoB 2: a revised tool for assessing risk of bias in randomised trials

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quantifying heterogeneity in a meta-analysis.

              The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions. This extent may be measured by estimating a between-study variance, but interpretation is then specific to a particular treatment effect metric. A test for the existence of heterogeneity exists, but depends on the number of studies in the meta-analysis. We develop measures of the impact of heterogeneity on a meta-analysis, from mathematical criteria, that are independent of the number of studies and the treatment effect metric. We derive and propose three suitable statistics: H is the square root of the chi2 heterogeneity statistic divided by its degrees of freedom; R is the ratio of the standard error of the underlying mean from a random effects meta-analysis to the standard error of a fixed effect meta-analytic estimate, and I2 is a transformation of (H) that describes the proportion of total variation in study estimates that is due to heterogeneity. We discuss interpretation, interval estimates and other properties of these measures and examine them in five example data sets showing different amounts of heterogeneity. We conclude that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity. One or both should be presented in published meta-analyses in preference to the test for heterogeneity. Copyright 2002 John Wiley & Sons, Ltd.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Med (Lausanne)
                Front Med (Lausanne)
                Front. Med.
                Frontiers in Medicine
                Frontiers Media S.A.
                2296-858X
                17 July 2023
                2023
                17 July 2023
                : 10
                : 1175827
                Affiliations
                School of Medicine, Huaqiao University , Quanzhou, China
                Author notes

                Edited by: Shisan Bao, The University of Sydney, Australia

                Reviewed by: Liyan Yang, Qufu Normal University, China; Kundlik Gadhave, Johns Hopkins University, United States

                *Correspondence: Lei Tong leitong007@ 123456163.com

                †These authors have contributed equally to this work

                Article
                10.3389/fmed.2023.1175827
                10387529
                dfcad4b4-fcb7-4f90-8407-7231d3a21355
                Copyright © 2023 Tong, Ma, Zhou, Yang, Yang, Luo, Huang and Wang.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 28 February 2023
                : 29 June 2023
                Page count
                Figures: 9, Tables: 3, Equations: 0, References: 114, Pages: 24, Words: 15248
                Funding
                This study was supported by the Natural Science Foundation of Fujian Province (2022J01311 to LT), the National Natural Science Foundation of China (81860354 to FW), and the Scientific Research Funds of Huaqiao University (21BS105 to LT and 605-50Y18058 to FW). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Medicine
                Systematic Review
                Custom metadata
                Infectious Diseases: Pathogenesis and Therapy

                chinese herbal medicine,covid-19,systematic review,meta-analysis,randomized controlled trials

                Comments

                Comment on this article